After the deal, GSK will have a majority controlling equity interest
of 68 per cent in the combined consumer healthcare business.
https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/cci-approves-gsk-pfizer-consumer-healthcare-jv-formation/articleshow/69478466.cms
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment